Immunotherapy for Australia-antigen-associated hepatoma.
D000349:Africa; D000510:Alpha-Globulins / Q000494:pharmacology; D001208:Asia; D006528:Carcinoma, Hepatocellular / Q000453:epidemiology / Q000276:immunology / Q000628:therapy*; D005078:Exchange Transfusion, Whole Blood; D005326:Fetal Proteins / Q000494:pharmacology; D006511:Hepatitis B Antigens; D006801:Humans; D007165:Immunosuppression Therapy; D007167:Immunotherapy; D008113:Liver Neoplasms / Q000453:epidemiology / Q000276:immunology / Q000628:therapy*; D008213:Lymphocyte Activation / Q000187:drug effects
D000510:Alpha-Globulins; D005326:Fetal Proteins; D006511:Hepatitis B Antigens